Initiation and Synergistic Fibrillization of Tau and Alpha-Synuclein

Giasson, Benoit I., Forman, Mark S., Higuchi, Makoto, Golbe, Lawrence I., Graves, Charles L., Kotzbauer, Paul T., Trojanowski, John Q., Lee, Virginia M.-Y.·2003·Science
DOI 10.1126/science.1082324

Cited by (879)

Items 601–700 of 879

  1. Isolation of short peptide fragments from α-synuclein fibril core identifies a residue important for fibril nucleation: A possible implication for diagnostic applications
    Hisashi Yagi, Hideki Takeuchi, Shiho Ogawa, Naomi Ito, Isao Sakane, Kunihiro Hongo, Tomohiro Mizobata, Yuji Goto, Yasushi Kawata · 2010 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  2. TDP-43 is associated with a reduced likelihood of rendering a clinical diagnosis of dementia with Lewy bodies in autopsy-confirmed cases of transitional/diffuse Lewy body disease
    Marina Buciuc, Jennifer Louise Whitwell, Bradley F. Boeve, Tanis J. Ferman, Jonathan Graff‐Radford, Rodolfo Savica, Kejal Kantarci, Julie A. Fields, David S. Knopman, Ronald Carl Petersen et al. · 2020 · Journal of Neurology
  3. α-Synuclein and tau, two targets for dementia
    Matías Silva, Valentina Caro, Camila Guzmán, George L. Perry, Carlos Areche, Alberto Cornejo · 2020 · Studies in natural products chemistry
  4. Trans‐seeding of Alzheimer‐related tau protein by a yeast prion
    Martin Flach, Cedric Leu, Alfonso Martinisi, Zhiva Kalinova Skachokova, Stephan Frank, Markus Tolnay, Henning Stahlberg, David T. Winkler · 2022 · Alzheimer s & Dementia
  5. Research models to study lewy body dementia
    Suelen Lucio Boschen, Aarushi A. Mukerjee, Ayman H. Faroqi, Benjamin E. Rabichow, John Denis Fryer · 2025 · Molecular Neurodegeneration
  6. Disease–disease interactions: molecular links of neurodegenerative diseases with cancer, viral infections, and type 2 diabetes
    Yuxi Lin, Je Min Yoo, Danni Li, Yunseok Heo, Masaki Okumura, Hyung‐Sik Won, Michele Vendruscolo, Mi Hee Lim, Young‐Ho Lee · 2025 · Translational Neurodegeneration
  7. The unique neuropathological vulnerability of the human brain to aging
    Isidró Ferrer · 2023 · Ageing Research Reviews
  8. Evaluation of the Therapeutic Effect of Lycoramine on Alzheimer’s Disease in Mouse Model
    İrem Kiris, Merve Karayel‐Basar, Betül Şahin, Büşra Gürel, Julide Coşkun, Tomasz Mroczek, Ahmet Tarık Baykal · 2020 · Current Medicinal Chemistry
  9. Targeted proteolytic products of τ and α-synuclein in neurodegeneration
    Yuxing Xia, Grace M. Lloyd, Benoit I. Giasson · 2021 · Essays in Biochemistry
  10. Untwisted α-Synuclein Filaments Formed in the Presence of Lipid Vesicles
    Anvesh K. R. Dasari, Lucas B. Dillard, Sujung Yi, Elizabeth G. Viverette, Alimohammad Hojjatian, Urmi Sengupta, Rakez Kayed, Kenneth A. Taylor, Mario Juan Borgnia, Kwang Hun Lim · 2022 · Biochemistry
  11. Synthetic Proteins and Peptides for the Direct Interrogation of α-Synuclein Posttranslational Modifications
    Matthew R. Pratt, Tharindumala Abeywardana, Nicholas P. Marotta · 2015 · Biomolecules
  12. Perirhinal accumulation of neuronal alpha‐synuclein in a multiple system atrophy patient with dementia
    Saito Mari, Makoto Hara, Momoko Ebashi, Akihiko Morita, Kyoko Okada, Taku Homma, Masahiko Sugitani, Kentaro Endo, Toshiki Uchihara, Satoshi Kamei · 2017 · Neuropathology
  13. MultiTEP platform–based DNA vaccines for alpha-synucleinopathies: preclinical evaluation of immunogenicity and therapeutic potency
    Hayk Davtyan, Karen Zagorski, Irina Petrushina, Konstantin Kazarian, Natalie R.S. Goldberg, Janet Petrosyan, Mathew M. Blurton-Jones, Eliezer Masliah, David H. Cribbs, Michael G. Agadjanyan et al. · 2017 · Neurobiology of Aging
  14. Alpha-synuclein transgenic mice: Relevance to multiple system atrophy
    Gwenaëlle Fillon, Philipp J. Kahle · 2005 · Movement Disorders
  15. Implications of protein structure instability: From physiological to pathological secondary structure
    Alyona V. Sukhanova, Simon Poly, Anton A. Shemetov, Igor B. Bronstein, Igor R. Nabiev · 2012 · Biopolymers
  16. Genetics of Parkinsonism
    Alistair J. Lewthwaite, David Joseph Nicholl · 2005 · Current Neurology and Neuroscience Reports
  17. Exosomes and MicroRNAs in Biomedical Science
    Hamed Mirzaei, Neda Rahimian, Hamid Reza Mirzaei, Javid Sadri Nahand, Michael Richard Hamblin · 2022 · Synthesis lectures on biomedical engineering
  18. Oligomerization by co-assembly of β-amyloid and α-synuclein
    Jin Ryoun Kim · 2023 · Frontiers in Molecular Biosciences
  19. Tau maturation in the clinicopathological spectrum of Lewy body and Alzheimer's disease
    Sanaz Arezoumandan, Katheryn A Q Cousins, Daniel T. Ohm, MaKayla Lowe, Min Chen, James C. Gee, Jeffrey S. Phillips, Corey T. McMillan, Kelvin C. Luk, Andres Deik et al. · 2024 · Annals of Clinical and Translational Neurology
  20. Structural basis of a distinct α-synuclein strain that promotes tau inclusion in neurons
    Chuanqi Sun, Kang Zhou, Peter DePaola, Cally Li, Virginia M.‐Y. Lee, Z. Hong Zhou, Chao Peng, Lin Jiang · 2025 · Journal of Biological Chemistry
  21. Cerebrospinal fluid α-synuclein predicts neurodegeneration and clinical progression in non-demented elders
    Alzheimer’s Disease Neuroimaging Initiative, Jieqiong Li, Yanlin Bi, Xue‐Ning Shen, Hui-Fu Wang, Wei Xu, Chen‐Chen Tan, Qiang Dong, Yan‐Jiang Wang, Lan Tan et al. · 2020 · Translational Neurodegeneration
  22. Interaction between SNCA, LRRK2 and GAK increases susceptibility to Parkinson's disease in a Chinese population
    Wen-Juan Yu, Lan Cheng, Nannan Li, Ling Wang, Eng‐King Tan, Rong Peng · 2015 · eNeurologicalSci
  23. Mechanistic approaches to understand the prion-like propagation of aggregates of the human tau protein
    Harish Kumar, Jayant B. Udgaonkar · 2019 · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics
  24. Relationship Between Tau, β Amyloid and α-Synuclein Pathologies
    Lauren Walker, Johannes Attems · 2019 · Advances in experimental medicine and biology
  25. Molecular Interpretation of ACTH-β-Endorphin Coaggregation: Relevance to Secretory Granule Biogenesis
    Srivastav Ranganathan, Pradeep Kumar Singh, Uday Singh, Praful S. Singru, Ranjith Padinhateeri, Samir Kumar Maji · 2012 · PLoS ONE
  26. Following the leader: fibrillization of ?-synuclein and tau
    Mark A. Frasier · 2004 · Experimental Neurology
  27. Reply to ‘TMEM230 variants in Parkinson’s disease’ and ‘Doubts about TMEM230 as a gene for parkinsonism’
    Han‐Xiang Deng, Margaret Ann Pericak‐Vance, Teepu Siddique · 2019 · Nature Genetics
  28. α-synuclein as an emerging pathophysiological biomarker of Alzheimer’s disease
    Maria Francesca Beatino, Ciro De Luca, Nicole Campese, Elisabetta Belli, Rebecca Piccarducci, Linda Giampietri, Claudia Martini, Giulio Perugi, Gabriele Siciliano, Roberto Ceravolo et al. · 2022 · Expert Review of Molecular Diagnostics
  29. Cerebrospinal fluid tau and disease progression in early Parkinson’s disease: an 8-year longitudinal study
    Xu Fang, Hongyan Huang, Jiaming Feng, Qiuyan Shen, Yi Bao, Dan Zhang, Yanming Xu · 2024 · Journal of Neurology
  30. Transmission of Tau Pathology Induced by Synthetic Preformed Tau Filaments
    Juan F. Reyes, Nolwen L. Rey, Élodie Angot · 2013 · Journal of Neuroscience
  31. MAPT mutations associated with familial tauopathies lead to formation of conformationally distinct oligomers that have cross‐seeding ability
    Anukool A. Bhopatkar, Nemil N. Bhatt, Md. Anzarul Haque, Rhea Xavier, Leiana Fung, Cynthia Jerez, Rakez Kayed · 2024 · Protein Science
  32. Complex proteinopathy with accumulations of prion protein, hyperphosphorylated tau, α-synuclein and ubiquitin in experimental bovine spongiform encephalopathy of monkeys
    Pedro Piccardo, Juraj Cervenak, Ming Bu, Lindsay Miller, David M. Asher · 2014 · Journal of General Virology
  33. Quantum dots induce charge-specific amyloid-like fibrillation of insulin at physiological conditions
    Alyona V. Sukhanova, Simon Poly, Anton A. Shemetov, Igor R. Nabiev · 2012 · Proceedings of SPIE, the International Society for Optical Engineering/Proceedings of SPIE
  34. A Genome-Wide Association Study of α-Synuclein Levels in Cerebrospinal Fluid
    Alzheimer’s Disease Neuroimaging Initiative, Xiao-ling Zhong, Jieqiong Li, Li Jiang Sun, Yaqing Li, Hui-Fu Wang, Xi‐Peng Cao, Chen‐Chen Tan, Ling Wang, Lan Tan et al. · 2018 · Neurotoxicity Research
  35. Characterizing the inhibition of α‐synuclein oligomerization by a pharmacological chaperone that prevents prion formation by the protein PrP
    Chunhua Dong, C. Garen, P. Mercier, N. Petersen, M. Woodside · 2019 · Protein Science
  36. Possible Role of Amyloid Cross-Seeding in Evolvability and Neurodegenerative Disease
    Makoto Hashimoto, Gilbert J. Ho, Yoshiki Takamatsu, Ryoko Wada, Shuei Sugama, Takato Takenouchi, Masaaki Waragai, Eliezer Masliah · 2019 · Journal of Parkinson s Disease
  37. Differences between normal and alpha-synuclein overexpressing SH-SY5Y neuroblastoma cells after Aβ(1-42) and NAC treatment
    Ákos Gábor Hunya, István Földi, Viktor Szegedi, Katalin Soós, Márta Zarándi, Antal Szabó, Dénes Zádori, Botond Penke, Zsolt Datki · 2007 · Brain Research Bulletin
  38. Impact of α-Synuclein Pathology on Aging
    Laura Parkkinen · 2005
  39. Co‐pathologies modify hippocampal protein accumulation patterns in neurodegenerative diseases
    Kōji Yoshida, Shelley L. Forrest, Shojiro Ichimata, Hidetomo Tanaka, Tomoya Kon, Gábor Géza Kovács · 2024 · Alzheimer s & Dementia
  40. Cortical microstructural abnormalities in dementia with Lewy bodies and their associations with Alzheimer’s disease copathologies
    Elijah Mak, Robert I. Reid, Scott A. Przybelski, Angela J. Fought, Timothy G. Lesnick, Christopher G. Schwarz, Matthew L. Senjem, Sheelakumari Raghavan, Prashanthi Vemuri, Clifford R. Jack et al. · 2025 · npj Parkinson s Disease
  41. Achalasie de l’œsophage, troubles du sommeil et mouvements choréiques au cours d’une taupathie sans ophtalmoplégie, syndrome parkinsonien ni démence (paralysie supranucléaire progressive ?) : étude clinicopathologique
    Elsa Kaphan, Jean‐François Pellissier, Marc F. Rey, Danièle Robert, M. Auphan, Ali Chérif · 2008 · Revue Neurologique
  42. High-Density Single-Layer Coating of Gold Nanoparticles onto Multiple Substrates by Using an Intrinsically Disordered Protein of α-Synuclein for Nanoapplications
    Ghibom Bhak, Junghee Lee, Chang‐Hyun Kim, Dong Young Chung, Jin Hyoun Kang, Soojung Oh, Jungsup Lee, Jin Soo Kang, Ji Mun Yoo, Jee Eun Yang et al. · 2017 · ACS Applied Materials & Interfaces
  43. Cross-seeding between the functional amyloidogenic CRES and CRES3 family members and their regulation of Aβ assembly
    Hoa Quynh Do, Aveline Hewetson, Collin G. Borcik, Mary Catherine Hastert, Sandra Whelly, Benjamin J. Wylie, Roger Bryan Sutton, Gail A. Cornwall · 2020 · Journal of Biological Chemistry
  44. Life Cycle of Yeast Prions: Propagation Mediated by Amyloid Fibrils
    Yuji Inoue · 2009 · Protein and Peptide Letters
  45. Lewy body dementia: exploring biomarkers and pathogenic interactions of amyloid β, tau, and α-synuclein
    Jingfeng Liang, Rongzhen Li, Garry Wong, Xiaobing Huang · 2025 · Molecular Neurodegeneration
  46. Tubulin transforms Tau and α-synuclein condensates from pathological to physiological
    Lathan Lucas, Phoebe S. Tsoi, My Diem Quan, Kyoung‐Jae Choi, Josephine C. Ferreon, Allan Chris M. Ferreon · 2026 · Nature Communications
  47. Variable tau accumulation in murine models with abnormal prion protein deposits
    Pedro Piccardo, Declan King, Deborah Brown, Rona M. Barron · 2017 · Journal of the Neurological Sciences
  48. Deposition of Phosphorylated α-Synuclein and Activation of GSK-3β and PP2A in the PS19 Mouse Model of Tauopathy
    Yuta Takaichi, James Kenn CHAMBERS, Yasuhisa Ano, Akihiko Takashima, Hiroyuki Nakayama, Kazuyuki Uchida · 2021 · Journal of Neuropathology & Experimental Neurology
  49. Relation between Alpha-Synuclein and Core CSF Biomarkers of Alzheimer’s Disease
    Victoria Monge‐García, María‐Salud García‐Ayllón, Javier Sáez‐Valero, José Sánchez–Payá, Francisco Navarrete, Jorge Manzanares, Ruth Gasparini‐Berenguer, Raquel Romero‐Lorenzo, María‐Ángeles Cortés‐Gómez, J.A. Monge-Argilés · 2021 · Medicina
  50. Advances in our Understanding of Neurodegeneration
    K. A. Jellinger · 2007 · Elsevier eBooks
  51. Yeast prions, mammalian amyloidoses, and the problem of proteomic networks
    Alexey P. Galkin, Ludmila N Mironova, Galina A. Zhouravleva, Sergey Georgievich Inge-Vechtomov · 2006 · Russian Journal of Genetics
  52. Midbrain catecholaminergic neurons co-express α-synuclein and tau in progressive supranuclear palsy
    María Elena Erro Aguirre, María Victoria Zelaya, Javier Sánchez‐Ruiz de Gordoa, María Teresa Tuñà n, José Luis Lanciego · 2015 · Frontiers in Neuroanatomy
  53. Attack on amyloid
    Philipp J. Kahle, Bart De Strooper · 2003 · EMBO Reports
  54. Diffuse Lewy Body Disease and Alzheimer Disease: Neuropathologic Phenotype Associated With the PSEN1 p.A396T Mutation
    Dibson Dibe Gondim, Adrian L. Oblak, Jill R. Murrell, Rose M. Richardson, Francine Epperson, Owen A. Ross, Bernardino Francesco Ghetti · 2019 · Journal of Neuropathology & Experimental Neurology
  55. Alzheimer’s Disease and Dementia
    Patrick Alfryn Lewis, Jennifer E. Spillane · 2018 · Elsevier eBooks
  56. Distinct cryo-EM Structure of α-synuclein Filaments derived by Tau
    Alimohammad Hojjatian, Anvesh K. R. Dasari, Urmi Sengupta, Dianne W. Taylor, Nadia Daneshparvar, Fatemeh Abbasi Yeganeh, Lucas B. Dillard, Brian C. Michael, Robert G. Griffin, Mario Juan Borgnia et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  57. Multivalency drives interactions of alpha-synuclein fibrils with tau
    Jennifer Ramirez, Ibrahim G. Saleh, Evan S. K. Yanagawa, Marie Shimogawa, Emily Brackhahn, E. James Petersson, Elizabeth R. Rhoades · 2024 · PLoS ONE
  58. Assessment of gastrointestinal function and enteric nervous system changes over time in the A53T mouse model of Parkinson’s disease
    Myat Noe Han, Madeleine R. Di Natale, Enie Lei, John B. Furness, David Isaac Finkelstein, Marlene M. Hao, Shanti Diwakarla, Rachel Mai McQuade · 2025 · Acta Neuropathologica Communications
  59. Co‐ and Multi‐Pathologies in Parkinson's Disease: An International Parkinson and Movement Disorder Society Scientific Issues Committee Review
    Michele Matarazzo, Per Borghammer, Inas Elsayed, Jennifer G. Goldman, Yue Huang, Katja Lohmann, Per Svenningsson, Lorraine V. Kalia, Daniela Berg, Jeffrey H. Kordower · 2026 · Movement Disorders
  60. What we can learn from animal models about cerebral multi-morbidity
    Siân L. Baker, Jürgen Götz · 2015 · Alzheimer s Research & Therapy
  61. Molecular Mechanisms of Emerging Therapeutic Targets in Alzheimer’s Disease: A Systematic Review
    T. Premkumar, Sajitha Lulu S · 2022 · Neurochemical Journal
  62. An Innate Host Defense Protein β2-Microglobulin Keeps a Check on α-Synuclein amyloid Assembly: Implications in Parkinson's Disease
    Khushboo Rani, Arumay Pal, Bharat Gurnani, Pratibha Agarwala, Dibyendu Kumar Sasmal, Neha Jain · 2023 · Journal of Molecular Biology
  63. Distinguishing Closely Related Amyloid Precursors Using an RNA Aptamer
    Claire J. Sarell, Theodoros K. Karamanos, Simon J. White, David H. J. Bunka, Arnout P. Kalverda, Gary S. Thompson, Amy Barker, Peter G. Stockley, Sheena E. Radford · 2014 · Journal of Biological Chemistry
  64. Repetitive mild TBI causes pTau aggregation in nigra without altering preexisting fibril induced Parkinson’s-like pathology burden
    Vedad Delic, Joshua H. Karp, Maynard Guzman, Gabriel R. Arismendi, Katherine J. Stalnaker, Julia A. Burton, Kathleen E. Murray, Joshua P. Stamos, Kevin D. Beck, Arpine Sokratian et al. · 2022 · Acta Neuropathologica Communications
  65. Mitochondria and Parkinson's Disease
    David K. Simon, Charleen T. Chu, Russell Howard Swerdlow · 2011 · Parkinson s Disease
  66. Other Proteins Involved in Parkinson's Disease and Related Disorders
    Fernando Cardona, Jordi Pérez‐Tur · 2016 · Current Protein and Peptide Science
  67. Expanded and Wild-type Ataxin-3 Modify the Redox Status of SH-SY5Y Cells Overexpressing α-Synuclein
    Carolina Noronha, Rita Perfeito, Mário Laço, Ullrich Wüllner, Ana Cristina Rego · 2017 · Neurochemical Research
  68. Chronological changes in the expression of phosphorylated tau and 5-AMP-activated protein kinase in the brain of senescence-accelerated P8 mice
    Hak‐Su Kim, Sohee Moon, Sujin Kim, Min-Jae Lee, Min Hwa Suk, Dong‐Ho Park, Dong Wun Shin, Chang‐Shin Park, Ju‐Hee Kang · 2017 · Molecular Medicine Reports
  69. Genetics of Parkinson's Disease
    Yue Ming Huang, Piu Chan, Glenda Margaret Halliday · 2007 · Elsevier eBooks
  70. Deposition of Phosphorylated α-Synuclein in the rTg4510 Mouse Model of Tauopathy
    Yuta Takaichi, Yasuhisa Ano, James Kenn CHAMBERS, Kazuyuki Uchida, Akihiko Takashima, Hiroyuki Nakayama · 2018 · Journal of Neuropathology & Experimental Neurology
  71. Correlation of tau gene polymorphism with age at onset of Parkinson's disease
    Hideaki Kobayashi, Hiroshi Ujike, Junko Hasegawa, Mitsutoshi Yamamoto, Akihiro Kanzaki, Ichiro Sora · 2006 · Neuroscience Letters
  72. Posterior hippocampal sparing in Lewy body disorders with Alzheimer’s copathology: An in vivo MRI study
    Jesse S. Cohen, Jeffrey T. Phillips, Sandhitsu R. Das, Christopher A. Olm, Hamsanandini Radhakrishnan, Emma Rhodes, Katheryn A Q Cousins, Sharon Xiangwen Xie, Ilya M. Nasrallah, Paul A. Yushkevich et al. · 2024 · NeuroImage Clinical
  73. Distinct subcellular localization of tau and alpha-synuclein in lewy body disease
    D. Luke Fischer, Marissa A. Menard, Omar Z. Abdelaziz, Nicholas M. Kanaan, Virginia G. Cobbs, Richard Kennedy, Geidy E. Serrano, Thomas G. Beach, Laura A. Volpicelli‐Daley · 2025 · Acta Neuropathologica Communications
  74. Bispecific Tau Antibodies with Additional Binding to C1q or Alpha-Synuclein
    Wim Hendricus Quint, Irena Matečko‐Burmann, Irene Schilcher, Tina Löffler, Michael Schöll, Björn M. Burmann, Thomas Vogels · 2021 · Journal of Alzheimer s Disease
  75. LRRK2; a dynamic regulator of cellular trafficking
    Jordan Follett, Matthew James Farrer · 2021 · Brain Research
  76. Mild cognitive impairment in dementia with Lewy bodies: an update and outlook
    K. A. Jellinger · 2023 · Journal of Neural Transmission
  77. Association of microtubule associated protein tau/Saitohin (MAPT/STH) MAPT_238bp/STH Q7R polymorphisms and Parkinson’s disease: A meta-analysis
    Shanshan Lu, Feng‐Feng Gong, Fang Feng, Caiyun Hu, Zhenzhong Qian, Yile Wu, Huiyun Yang, Yehuan Sun · 2014 · Biochemical and Biophysical Research Communications
  78. [Progression of gestational hypertension to preeclampsia].
    Juan Fernando Romero-Arauz, Cristina Basilisa Ortiz-Díaz, Alfredo Leaños‐Miranda, Óscar Arturo Martínez-Rodríguez · 2014 · PubMed
  79. FaptaSyme: A Strategy for Converting a Monomer/Oligomer‐Nonselective Aptameric Sensor into an Oligomer‐Selective One
    Baggio Evangelista, Yoon‐Seong Kim, Dmitry M. Kolpashchikov · 2018 · ChemBioChem
  80. Lewy Body Degenerations as Neuropsychiatric Disorders
    Jared T. Hinkle, Gregory M. Pontone · 2020 · Psychiatric Clinics of North America
  81. Small Heat Shock Proteins and the Cytoskeleton
    Christiane Richter‐Landsberg, Olaf Goldbaum · 2009 · Springer eBooks
  82. Amyloids as Sensors and Protectors (ASAP) Hypothesis
    Rachel Petrofes Chapa, Michael A. Emery, Janelle N. Fawver, Ian V.J. Murray · 2012 · Journal of Alzheimer s Disease
  83. Neuropathology
    K. A. Jellinger · 2013 · Springer eBooks
  84. Commentary: alpha-synuclein interacts with SOD1 and promotes its oligomerization
    Karin M. Danzer · 2016 · Journal of Neurology and Neuromedicine
  85. Alpha‐Synuclein Demonstrates Varying Binding Affinities With Different Tau Isoforms
    Anna‐Lisa Fischer, Matthias Schmitz, Tobias Thom, Saima Zafar, Neelam Younas, Susana Correia, Angela da Silva Correia, Sezgi Canaslan, Inga Zerr · 2025 · Journal of Neurochemistry
  86. Molecular Crossroads: Shared and Divergent Molecular Signatures in Alzheimer’s Disease and Dementia with Lewy Bodies
    Sandesh Neupane, Tibor Hortobágyi · 2025 · International Journal of Molecular Sciences
  87. Are Parkinson’s Disease Patients the Ideal Preclinical Population for Alzheimer’s Disease Therapeutics?
    Thomas Francis Tropea, Alice S. Chen‐Plotkin · 2021 · Journal of Personalized Medicine
  88. The Biology and Pathobiology of Tau Protein
    Garth F. Hall · 2012 · Humana Press eBooks
  89. Parkinson-ALS with a novel MAPT variant
    Camilla Ferrari, Assunta Ingannato, Sabrina Matà, Silvia Ramat, Luca Caremani, Silvia Bagnoli, Valentina Bessi, Sandro Sorbi, Benedetta Nacmias · 2023 · Neurological Sciences
  90. Differential induction of mutant SOD1 misfolding and aggregation by tau and α-synuclein pathology
    Michael C. Pace, Guilian M. Xu, Susan Fromholt, John Clair Howard, Benoit I. Giasson, Jada M. Lewis, David Borchelt · 2018 · Molecular Neurodegeneration
  91. Different types of amyloid concomitantly present in the same patients
    Francesca Martini, Gabriele Buda, Vincenzo De Tata, Sara Galimberti, Enrico Orciuolo, Matilde Masini, Mario Petrini · 2019 · Hematology Reports
  92. The Aβ42 Peptide and IAPP Physically Interact in a Yeast-Based Assay
    Daniel V. Kachkin, Veronika V. Lashkul, Natalia A. Gorsheneva, Sergey A. Fedotov, Maria S. Rubel, Yury O. Chernoff, Aleksandr A. Rubel · 2023 · International Journal of Molecular Sciences
  93. Effects of task-specific rehabilitation training on tau modification in rat with photothrombotic cortical ischemic damage
    Kyung‐Lim Joa, Sohee Moon, Ji-Hye Kim, Dong Wun Shin, Kyoung‐Hee Lee, Seon Ho Jung, Myeong-Ok Kim, Chang-Hwan Kim, Han Young Jung, Ju‐Hee Kang · 2017 · Neurochemistry International
  94. Dementia With Lew Body
    Farzana Pervin, Carolyn Y. Edwards, Carol Frances Lippa · 2015 · American Journal of Alzheimer s Disease & Other Dementias®
  95. Characterization of α-synuclein oligomers formed in the presence of lipid vesicles
    Anvesh K. R. Dasari, Urmi Sengupta, Elizabeth G. Viverette, Mario Juan Borgnia, Rakez Kayed, Kwang Hun Lim · 2024 · Biochemistry and Biophysics Reports
  96. Nonintuitive Immunogenicity and Plasticity of Alpha-Synuclein Conformers: A Paradigm for Smart Delivery of Neuro-Immunotherapeutics
    Amos Olusegun Abioye, Damilare D. Akintade, James Mitchell, Simisade Olorode, Adeboye Adejare · 2024 · Pharmaceutics
  97. The Role of the Claustrum in Parkinson’s Disease and Vascular Parkinsonism: A Matter of Network?
    Marialuisa Zedde, R. Quatrale, Gianni Cossu, Massimo Del Sette, Rosario Pascarella · 2025 · Life
  98. The genetic predictors of cognitive impairment in Parkinson's disease
    Konstantin A. Senkevich, Irina V. Miliukhina, С. Н. Пчелина · 2018 · S S Korsakov Journal of Neurology and Psychiatry
  99. TMEM106B C‐terminal fragments aggregate and drive neurodegenerative proteinopathy in transgenic Caenorhabditis elegans
    Ruben Riordan, Aleen D. Saxton, Marina Han, Pamela J. McMillan, Rebecca L. Kow, Nicole F. Liachko, Brian C. Kraemer · 2024 · Alzheimer s & Dementia
  100. Multimer Detection System: A Universal Assay System for Differentiating Protein Oligomers from Monomers
    Angelo Jamerlan, Kyu Hwan Shim, Niti Sharma, Seong Soo A. An · 2025 · International Journal of Molecular Sciences